mBio
@mbiojournal
The American Society for Microbiology’s first broad-scope, online-only, open-access journal. Contact us at [email protected].
ID:54956437
http://mbio.asm.org/ 08-07-2009 17:04:11
5,5K Tweets
27,5K Followers
369 Following
Follow People
#FightAgainstMalaria This is the first time that a CAF01-adjuvanted asexual whole blood-stage parasite vaccine has been assessed for efficacy and immunogenicity in rodent models of malaria. Results have informed transition to clinical trials. Dr. Winter Okoth, PhD. journals.asm.org/doi/10.1128/mb…
A catalytic adjuvant to enhance T cell immunogenicity of LNP vaccines. Kagan and colleagues report that mRNAs that encode adjuvant proteins can boost T cell responses to mRNAs that encode antigens. Jonathan Kagan Dania Zhivaki Emily Gosselin #mBio journals.asm.org/doi/10.1128/mb…
Eukaryotic genomes from a global metagenomic dataset illuminate trophic modes and biogeography of ocean plankton. Harriet Alexander Sarah K. Hu #mBio journals.asm.org/doi/10.1128/mb…
COVID-19 is transmitted every day worldwide. Waves of infections have indicated that the virus will likely persist as an endemic pathogen with distinct surges. But will it be seasonal? Jeffrey Townsend and coauthors have an answer, depending on where you are. journals.asm.org/doi/10.1128/mb…
Empower the microbial sciences at #ASMicrobe 2024! Explore topics like bacterial biosensors & discovering antibiotics in unculturable microbes. With 93% success rate from abstract submitters, become part of our success story! Submission opens Nov. 15. asm.social/1zk
How does the cellular protein RPRD2 block HIV infection? In this #mbio review, Dr Kathryn Jackson-Jones, Aine McKnight & Sloan Lab chart our understanding across 20+ years, from an unmapped antiviral phenotype (Lv2) through to the outstanding questions. journals.asm.org/doi/10.1128/mb…
New #mBio article explores the potential role of a novel β-lactam enhancer mechanism of action candidate drug, cefepime/zidebactam, in offering a treatment option for infections caused by extensively drug-resistant P. aeruginosa. armack balaji Veeraraghavan journals.asm.org/doi/10.1128/mb…